BSE’s Department of Surveillance (DOSS) has revised price bands for 28 equity scrips effective April 21, 2026. The revised bands range from 2% to 10%, limiting daily price movement for these securities as part of ongoing surveillance measures.

Key Points

• 28 scrips have price bands revised effective April 21, 2026
• Price bands are set to one of three levels: 2%, 5%, or 10%
• Two scrips (Natural Biocon India Ltd – 543207, Saptak Chem And Business Ltd – 506906) are assigned the most restrictive 2% band
• Twelve scrips are assigned a 5% band
• Fourteen scrips are assigned a 10% band
• Members may seek clarification at bse.surv@bseindia.com

Regulatory Changes

Price bands for the listed scrips have been revised from their existing levels. The new bands restrict intraday price movement to the specified percentage above or below the previous closing price.

Compliance Requirements

Trading members must note the revised price bands and ensure trading systems reflect the updated limits for affected scrips from April 21, 2026 onwards. No filing or reporting obligation is imposed on members.

Important Dates

• Notice Date: April 20, 2026
• Effective Date: April 21, 2026

Impact Assessment

The revision restricts daily price movement for 28 scrips, which may limit volatility and speculative trading in these securities. Scrips assigned a 2% band (Natural Biocon India Ltd and Saptak Chem And Business Ltd) face the most stringent restrictions, indicating heightened surveillance concern. Traders holding positions in these scrips should be aware of tighter circuit limits when placing orders from April 21, 2026.